Current Cancer Drug Targets

Home

Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
CONTENTS & ABSTRACTS
CONTACT US

Wednesday, December 28, 2016

Home » » Call For Paper

Call For Paper

10:52 PM No comments

Call For Paper

Email This BlogThis!Share to X Share to Facebook

Related Posts:

Open Access Article: Pleiotropic Role of HSF1 in Neoplastic Transformation Open Access Article: Pleiotropic Role of HSF1 in Neoplastic Transformation … Read More
New Issue Published Current Cancer Drug Targets Vol. 17 Issue 3 New Issue Published Current Cancer Drug Targets Vol. 17 Issue 3 … Read More
Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions … Read More
Free Trial Request Free Trial Request … Read More
Free Online Issue Current Cancer Drug Targets Vol. 17 Issue 1 Free Online Issue Current Cancer Drug Targets Vol. 17 Issue 1 … Read More

← Newer Post Older Post → Home

0 comments:

Post a Comment

Social Profiles

Blogroll

Popular
Tags
Blog Archives

New Issue Published Current Cancer Drug Targets Vol 18 issue 3

New Issue Published Current Cancer Drug Targets Vol 18 issue 3
Indian Authors have made substantial contributions to Bentham Science Journal Current Cancer Drug Targets

Indian Authors have made substantial contributions to Bentham Science Journal Current Cancer Drug Targets Journal Name: Current Canc...
Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives

Author(s): Rena Chiotaki, Hara Polioudaki and Panayiotis A. TheodoropoulosPages 256-269 (14) Abstract: Breast cancer stem cells (BCSCs...
Highlighted Article: Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening

Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening Author(s): ...
New Issue Published Current Cancer Drug Targets Vol 17 issue 9

New Issue Published Current Cancer Drug Targets Vol 17 issue 9
Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

Author(s): Rui Zhou, Zongliang Lu, Kai Liu, Jing Guo, Jie Liu, Yong Zhou, Jian Yang, Mantian Mi and Hongxia XuPages 860-871 (12) Abstra...
Issue ::: Current Cancer Drug Targets, 16 Issue 7

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecula...
Pleiotropic Role of HSF1 in Neoplastic Transformation

Author(s): Natalia Vydra, Agnieszka Toma and Wieslawa WidlakPages 144-155 (12) Abstract: HSF1 (Heat Shock transcription Factor 1) is t...
Free Trial Request

Free Trial Request
Open Access Plus Article in the journal Current Cancer Drug Targets

The article entitled ‘Pleiotropic Role of HSF1 in Neoplastic Transformation’ in the journal Current Cancer Drug Targets, 2014, 14, 144-...

Blog Archive

► 2018 (3)
- ► April (1)
- ► February (1)
- ► January (1)

► 2017 (36)
- ► December (1)
- ► October (4)
- ► September (1)
- ► August (4)
- ► July (4)
- ► June (2)
- ► May (4)
- ► April (3)
- ► March (4)
- ► February (3)
- ► January (6)

▼ 2016 (24)
- ▼ December (6)
- ► November (4)
- ► October (8)
- ► August (1)
- ► June (5)

BTemplates.com

Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives

Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

Pleiotropic Role of HSF1 in Neoplastic Transformation

Blogroll

About

Copyright © 2025 Current Cancer Drug Targets | Powered by Blogger

Design by FThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | NewBloggerThemes.com